References
- Huang J., Qian Z., Gong Y., Wang Y., Guan Y., Han Y., et al. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning. J. Med. Genet. 2018; 56:186–194. doi: 10.1136/jmedgenet-2018-105745.
- American Cancer Society. Cancer facts & figures 2018. Atlanta, GA: American Cancer Society, 2018.
- World health Organization (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021:71:209–49. doi:10.3322/caac.21660.
- Todor RD, Bratucu G, Moga MA, Candrea AN, Marceanu LG, Anastasiu CV. Challenges in the Prevention of Cervical Cancer in Romania. Int J Environ Res Public Health. 2021 Feb 10;18(4):1721. doi: 10.3390/ijerph18041721.
- Voidăzan, T.S.; Budianu, M.A.; Rozsnyai, F.F.; Kovacs, Z.; Uzun, C.C.; Neagu, N. Assessing the Level of Knowledge, Beliefs and Acceptance of HPV Vaccine: A Cross-Sectional Study in Romania. Int. J. Environ. Res. Public Health 2022, 19, 6939. https://doi.org/10.3390/ijerph19116939
- Chatterjee S., Gupta D., Caputo T.A., Holcomb K. Disparities in Gynecological Malignancies. Front. Oncol. 2016; 6:36. doi: 10.3389/fonc.2016.00036.
- Bosch FX, De Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007; 23(4): 213–227.
- Kahn J.A. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N. Engl. J. Med. 2009; 361:271–278. doi: 10.1056/NEJMct0806938.
- Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F, et al. High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies. Womens Health (Lond). 2022;18:17455065221075904. doi: 10.1177/17455065221075904.
- Chrysostomou A.C, Stylianou D.C, Constantinidou A, Kostrikis L.G. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses. 2018 Dec 19;10(12):729. doi: 10.3390/v10120729.
- Panczyszyn A., Bernacka E.B., Głab G., Telomeres and Telomerase During Human Papillomavirus Induced Carcinogenesis, Mol Diagn Ther, 2018 22:421–430 https://doi.org/10.1007/s40291-018-0336
- Molano M., Martín D.C., Acosta P.M, Hernández G, Cornall A., Buitrago O., et al. Telomerase activity in cervical scrapes of women with high grade cervical disease: A nested case control study, Oncology Letters. 2017; 15:354-360, DOI: 10.3892/ol.2017.7324
- He, H.; Pan, Q.; Pan, J.; Chen, Y.; Cao, L. Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer. J. Clin. Lab. Anal. 2020; 34, e23257. https://doi.org/10.1002/jcla.23257.
- Ji, W.; Lou, W.; Hong, Z.; Qiu, L.; Di, W. Genomic amplification of HPV, h‐TERC and c‐MYC in liquid‐based cytological specimens for screening of cervical intraepithelial neoplasia and cancer. Oncol. Lett. 2019; 17:2099–2106. https://doi.org/10.3892/ol.2018.9825.
- https://resources.rndsystems.com/pdfs/datasheets/dfbn10.pdf
- Voidăzan, S.T.; Dianzani, C.; Husariu, M.A.; Geréd, B.; Turdean, S.G.; Uzun, C.C.; Kovacs, Z.; Rozsnyai, F.F.; Neagu, N. The Role of p16/Ki‐67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review. Biology 2022, 11, 956. https://doi.org/10.3390/biology11070956
- Nayar R, Wilbur DC. The Pap test and Bethesda. Cancer Cytopathol 2015;123:271–81.
- Jahic M, Jahic E. Diagnostic approach to patients with atypical squamous cells of undetermined significance cytologic findings on cervix. Med Arch 2016;70:296–8.
- https://www.lsbio.com/elisakits/manualpdf/ls-f12713.pdf